Microbial Transformation of Cycloastragenol and Astragenol by Endophytic Fungi Isolated from Astragalus Species

被引:23
作者
Ekiz, Giiner [1 ,6 ]
Yilmaz, Sinem [2 ,7 ]
Yusufoglu, Hasan [3 ]
Kirmizibayrak, Petek Ballar [4 ]
Bedir, Erdal [5 ]
机构
[1] Near East Univ, Fac Pharm, Dept Pharmaceut Microbiol, Mersin 10, Nicosia, Turkey
[2] Univ Alanya Aladdin Keykubat, Fac Engn, Dept Bioengn, TR-07400 Antalya, Turkey
[3] Prince Sattam Bin Abdulaziz Univ, Coll Pharm, Dept Pharmacognosy, Al Kharj 11942, Saudi Arabia
[4] Ege Univ, Fac Pharm, Dept Biochem, TR-35100 Bornova, Turkey
[5] Izmir Inst Technol, Fac Engn, Dept Bioengn, TR-35430 Urla Izmir, Turkey
[6] Ege Univ, Grad Sch Nat & Appl Sci, Dept Bioengn, TR-35100 Bornova, Turkey
[7] Ege Univ, Grad Sch Nat & Appl Sci, Dept Biotechnol, TR-35100 Bornova, Turkey
来源
JOURNAL OF NATURAL PRODUCTS | 2019年 / 82卷 / 11期
关键词
TELOMERASE ACTIVATOR; HEALTH SPAN; BIOTRANSFORMATION; BIOCATALYSIS; TRITERPENOIDS;
D O I
10.1021/acs.jnatprod.9b00336
中图分类号
Q94 [植物学];
学科分类号
071001 ;
摘要
Biotransformation of Astragalus sapogenins (cycloastragenol (1) and astragenol (2)) by Astragalus species originated endophytic fungi resulted in the production of five new metabolites (3, 7, 10, 12, 14) together with 10 known compounds. The structures of the new compounds were established by NMR spectroscopic and HRMS analysis. Oxygenation, oxidation, epoxidation, dehydrogenation, and ring cleavage reactions were observed on the cycloartane (9,19-cyclolanostane) nucleus. The ability of the compounds to increase telomerase activity in neonatal cells was also evaluated. After prescreening studies to define potent telomerase activators, four compounds were selected for subsequent bioassays. These were performed using very low doses ranging from 0.1 to 30 nM compared to the control cells treated with DMSO. The positive control cycloastragenol and 8 were found to be the most active compounds, with 5.2- (2 nM) and 5.1- (0.5 nM) fold activations versus DMSO, respectively. At the lowest dose of 0.1 nM, compounds 4 and 13 provided 3.5- and 3.8-fold activations, respectively, while cycloastragenol showed a limited activation (1.5-fold).
引用
收藏
页码:2979 / 2985
页数:7
相关论文
共 39 条
[1]   Microbial transformation of Astragalus sapogenins using Cunninghamella blakesleeana NRRL 1369 and Glomerella fusarioides ATCC 9552 [J].
Bedir, Erdal ;
Kula, Ceyda ;
Oner, Ozlem ;
Altas, Melis ;
Tag, Ozgur ;
Ongen, Gaye .
JOURNAL OF MOLECULAR CATALYSIS B-ENZYMATIC, 2015, 115 :29-34
[2]   Potential of telomerase activation in extending health span and longevity [J].
Bernardes de Jesus, Bruno ;
Blasco, Maria A. .
CURRENT OPINION IN CELL BIOLOGY, 2012, 24 (06) :739-743
[3]   The telomerase activator TA-65 elongates short telomeres and increases health span of adult/old mice without increasing cancer incidence [J].
Bernardes de Jesus, Bruno ;
Schneeberger, Kerstin ;
Vera, Elsa ;
Tejera, Agueda ;
Harley, Calvin B. ;
Blasco, Maria A. .
AGING CELL, 2011, 10 (04) :604-621
[4]   Microbial Biotransformation to Obtain New Antifungals [J].
Bianchini, Luiz F. ;
Arruda, Maria F. C. ;
Vieira, Sergio R. ;
Campelo, Patrcia M. S. ;
Gregio, Ana M. T. ;
Rosa, Edvaldo A. R. .
FRONTIERS IN MICROBIOLOGY, 2015, 6
[5]  
Borges WD, 2009, CURR ORG CHEM, V13, P1137
[6]   Microbial cells as catalysts for stereoselective red-ox reactions [J].
Carballeira, J. D. ;
Quezada, M. A. ;
Hoyos, P. ;
Simeo, Y. ;
Hernaiz, M. J. ;
Alcantara, A. R. ;
Sinisterra, J. V. .
BIOTECHNOLOGY ADVANCES, 2009, 27 (06) :686-714
[7]   Whole cell biocatalysts: essential workers from Nature to the industry [J].
de Carvalho, Carla C. C. R. .
MICROBIAL BIOTECHNOLOGY, 2017, 10 (02) :250-263
[8]   Enzymatic and whole cell catalysis: Finding new strategies for old processes [J].
de Carvalho, Carla C. C. R. .
BIOTECHNOLOGY ADVANCES, 2011, 29 (01) :75-83
[9]   Novel telomerase-increasing compound in mouse brain delays the onset of amyotrophic lateral sclerosis [J].
Eitan, Erez ;
Tichon, Ailon ;
Gazit, Aviv ;
Gitler, Daniel ;
Slavin, Shimon ;
Priel, Esther .
EMBO MOLECULAR MEDICINE, 2012, 4 (04) :313-329
[10]  
Ekiz G., 2016, THESIS